Clinigen Group PLC (CLINC.L) Quote| Reuters.com
Edition:
United States

Clinigen Group PLC (CLINC.L)

CLINC.L on London Stock Exchange

582.75GBp
10:24am EDT
Change (% chg)

30.00p (+5.43%)
Prev Close
553.00p
Open
554.50p
Day's High
585.00p
Day's Low
554.50p
Volume
97,319
Avg. Vol
488,897
52-wk High
773.50p
52-wk Low
492.75p

CLINC.L

Chart for CLINC.L

About

Clinigen Group plc is a United Kingdom-based global pharmaceutical and services company. The Company consists of four businesses that provide medicines to patients with unmet needs, through clinical trials, licensed and unlicensed supply. It operates through four segments: Clinigen Clinical Trial Services (CTS), Idis Managed... (more)

Overall

Beta: 0.68
Market Cap(Mil.): £633.58
Shares Outstanding(Mil.): 114.57
Dividend: 1.30
Yield (%): --

Financials

  CLINC.L Industry Sector
P/E (TTM): -- 39.54 34.69
EPS (TTM): -0.01 -- --
ROI: 0.49 -6.70 14.13
ROE: -0.21 -6.13 15.35

BRIEF-Clinigen, Cumberland enter into U.S. commercialisation deal for ethyol

* Co and Cumberland Pharmaceuticals enter into exclusive u.s. Commercialisation agreement for oncology support drug ethyol Source text for Eikon: Further company coverage:

May 10 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Peel Hunt
$449.00
Provider : Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.